Pharmacokinetic and pharmacodynamic responses in adult patients with Chagas disease treated with a new formulation of benznidazole

Pharmacological treatment of Chagas disease with benznidazole (BNZ) is effective in children in all stages, but it is controversial in chronically infected adults. We report the pharmacokinetics and pharmacodynamics in six adult patients with Chagas disease treated with the new BNZ formulation (ABARAX®) in doses between 2.5-5.5 mg/Kg/day. All but one patient had plasmatic BNZ concentrations within the expected range. All patients finalised treatment with nondetectable Trypanosoma cruziquantitative polymerase chain reaction, which remained nondetectable at the six month follow-up. Our data suggests parasitological responses with the new BNZ and supports the hypothesis that treatment protocols with lower BNZ doses may be effective.

Latin 14872

Contient : I Quatuor libri de claustra anime ; Catalogues, tableaux et notes historiques et géographiques, attribuées à Hugues de Saint-Victor (45) ; II Proses d'Adam de Saint-Victor ; III Proses de N. Hamel

Report of Recommendations to Iowa State University of Science and Technology, June 30, 2003

State University Audit Report

Els apareguts i el culte de les ànimes del Purgatori (segles XIV-XVII). Estudi i edició de textos catalans

Report for the scientific sojourn carried out at the Institut National d'Histoire de l'Art (INHA), France, from 2010 to 2012. It has focused on the analysis and editing of tales of human apparitions from the other world belonging to the Catalan culture or referring to it. We have studied and edited different versions of the process of Esperança Alegre (Lleida, 1500) and the Peregrinació del Venturós Pelegrí. These medieval works have been preserved in sources of the late sixteenth century or later. We have located a manuscript of the Esperança Alegre's tale, unknown to us at the beginning of this research (Biblioteca Nacional de España, ms. 1701), which differs from the version of ms. Baluze 238 of the Bibliothèque Nationale de France. The scribe of the ms. 1701 adds several paragraphs where considers the case as a diabolical phantasmagoria. About the Venturós Pelegrí, we have tried to establish firm criteria for the classification of many editions from the seventeenth to nineteenth centuries. We have been looking for printed books in the libràries of the world and we have made several requests for photographic reproductions, in order to classify undated editions by comparing woodcuts and other decorative elements. In the legend of Prince Charles of Viana (1421-1461), the appearances of his ghost are accompanied by rumors of his poisoning and of his sanctity. In addition, we have studied the cycles of masses for the souls in Purgatory linked to the hagiographies of St. Amadour and St. Vincent Ferrer, as well as the appearances described in L'Ànima d’Oliver of Francesc Moner, in the Carmelite chronicles of Father John of St. Joseph (1642-1718) and in some folktales collected from the eighteenth to the twentieth century. All this have allowed us to verify the evolution of certain cultural paradigms since the Middle Ages to the present.

Stress e coping no período perioperatório de câncer de mama

Este trabalho é uma revisão bibliográfica, que objetiva refletir sobre stress e coping no perioperatório de câncer de mama, realizada em bases de dados on-line nacionais, abrangendo trabalhos publicados de 1996 a 2006. Foram encontrados 63 artigos, sendo selecionados 17, que foram lidos, analisados e agrupados em categorias temáticas: 1) O câncer de mama como estressor e o impacto do diagnóstico; 2) Stress e o tratamento do câncer de mama; 3) Coping e o câncer de mama, e 4) O enfermeiro como colaborador do processo de enfrentamento. Esse trabalho permitiu identificar que é vasta a literatura nacional sobre câncer de mama, mas poucos são os trabalhos que enfatizam stress e câncer de mama como processo vivenciado pela paciente. Por isso, pode dar direção a pesquisas futuras acerca dos estressores vivenciados pela mulher com câncer de mama no Brasil, e quais as estratégias de coping que ela utiliza para enfrentá-los.

La infàmia de tenir sang jueva a la Catalunya moderna: ecos del Reial Consell i de la literatura jurídica

El modest propòsit de la nostra participació en aquesta miscel·lània és posar de relleu dues importants resolucions adoptades al Reial Consell i Audiència de Catalunya a principi de la dècada de 1580, en relació amb discriminacions per motius de genealogia i de pretesa condició o sang jueva. Dóna fe de la rellevància de tals resolucions el fet que fossin comentades amb deteniment per dos autors de literatura jurídica cabdal com Lluís de Peguera (1540-1610) iJoan Pere Fontanella (1575-1649). Per bé que tinguessin trajectòries professionals molt dissímils –el primer seria ministre de la monarquia al Principat i el segon advocat de grans corporacions i particulars–, ambdós contribuirien a difondre sentències de les principals jurisdiccions del país i s’esplaiarien sobre llurs fonaments legals i doctrinals. És a dir, cultivarien, cadascú a la seva manera, el gènere ‘decisionista’ tan en boga a l’Europa moderna del ius commune tardà.

Patient-specific computational hemodynamics of intracranial aneurysms from 3D rotational angiography and CT angiography: an in vivo reproducibility study

Patient-specific simulations of the hemodynamics in intracranial aneurysms can be constructed by using image-based vascular models and CFD techniques. This work evaluates the impact of the choice of imaging technique on these simulations

MGMT promoter methylation in malignant gliomas.

The O(6)-methylguanine-DNA methyltransferase (MGMT) gene is located at chromosome 10q26 and codes for a DNA repair enzyme that--if active--can counteract the effects of alkylating chemotherapy. Malignant gliomas often have the MGMT gene inactivated due to aberrant methylation of its promoter region. The assessment of the MGMT promoter methylation status has become of clinical relevance as a molecular marker associated with response to alkylating chemotherapy and prolonged survival of glioblastoma patients. MGMT promoter methylation testing is also on the merge of being used as a marker for patient selection within clinical trials, e.g., the current CENTRIC trial that is specifically focusing on patients with MGMT promoter-methylated glioblastomas. In anaplastic gliomas, MGMT promoter methylation is a favorable prognostic marker independent of the type of therapy, i.e., radio- or chemotherapy. This occurrence might be associated with the high incidence of other prognostically favorable molecular markers in these tumors, such as IDH1 mutation, 1p/19q deletion or yet to be identified novel aberrations. A variety of different methods are being used to assess MGMT promoter methylation in clinical samples, which may give rise to inter-laboratory variations in test results. Immunohistochemical determination of MGMT protein expression has not proven reliable for diagnostic purposes. This brief review article aims to summarize the main aspects of MGMT promoter methylation testing in contemporary neuro-oncology, in particular its value as a clinically useful molecular marker, putting it into the context of other molecular markers of clinical use in gliomas of adult patients.